In2Sight | 4th annual meeting 3RS congress

September 14, 2023

At ASPHALION, we are part of the IN2SIGHT consortium, an EU-funded project, and we are delighted to be currently participating in the 4th annual meeting at the 3Rs congress in Milano: “The role of 3Rs in the age of One Health: where we are and where we’re going”.

In2Sight aims at fostering an unprecedented breakthrough in in-vivo optical imaging that will radically renew the biocompatibility tests of biomaterials.

Our expert Marta Rayo Lunar is giving a talk about the REGULATORY ASPECTS OF 3Rs: “Paving the Way for New In Vivo Validation Alternatives”, where she will cover the main regulatory guidelines and regulatory bodies related to the 3Rs in medicinal development.

For any further information about In2Sight or EU-funded projects, you can contact us at: [email protected]

Search News & Events

  • Filter by category


Related news and events

Clinical Trial Support in the EU

For companies engaged in clinical development programs for pharmaceutical products, robust regulatory support is essential for obtaining trial approval and initiation, as well as maintaining

FORCE REPAIR | 3rd Progress Meeting

Last week, the Force Repair project partners met in Pavia, Italy, for the the 3rd progress meeting. ASPHALION expert Jon Giblin attended the meeting, providing

RBDCOV | Project extension

The European Commission has granted a fifteen-month extension to the EU-funded RBDCOV project, extending the journey to August 31, 2025. This extra time is crucial

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting